Skip to main content

Laura García Latorre

I am a TSS (Higher Health Laboratory Technician). I started my professional career at the ICS in 1987 working at the Good Shepherd Laboratory and in 1992 I joined the Vall d'Hebron Hospital. The Biochemistry laboratory was the first service I was in and shortly afterwards I passed CIBBIM. In all these years I have seen and experienced the transformation of the campus. I am currently continuing at CIBBIM-Nanomedicina specifically in the DDT group which has a laboratory located in the Collserola VHIR building and another in the Mediterrània VHIR building.

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
CIBBIM
General Hospital

Laura García Latorre

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
CIBBIM
General Hospital

I am a TSS (Higher Health Laboratory Technician). I started my professional career at the ICS in 1987 working at the Good Shepherd Laboratory and in 1992 I joined the Vall d'Hebron Hospital. The Biochemistry laboratory was the first service I was in and shortly afterwards I passed CIBBIM. In all these years I have seen and experienced the transformation of the campus. I am currently continuing at CIBBIM-Nanomedicina specifically in the DDT group which has a laboratory located in the Collserola VHIR building and another in the Mediterrània VHIR building.

During all these years I have worked with different biological samples and I have carried out different test techniques
- Biochemistry: Detection of general clinical biochemistry parameters (routine biochemistry).
Quantification of electrolytes, specific lipids, hormones, proteinograms and immunological techniques in blood. Mass spectrometry techniques: metabolic studies in urine (nitrogen balance), detection of Helicobacter pylori in breath. Preparation of parenteral nutrition and its control in experimental animals Quantification of amino acids by HPLC in tissues. Fluoroimmunoassay. nephelometry

- Molecular biology. Bacteria growth. Gene cloning and sequencing. Extraction, quantification and analyzes of DNA, RNA and proteins. qRT-PCR. Western blot. Processing of tissue samples and subsequent lipid extraction. Enzyme activities. Electrophoresis with radioactive isotopes

- Cell biology. Culture of tumor cell lines. Primary cultures of skin biopsies and Amniotic Fluid. Cell viability and proliferation assays, cell cycle and apoptosis analyses. Flow cytometry.

- Pathological anatomy. Immunohistochemistry.

- ISO9001: Quality Management Systems

Projects

Impacto y valor pronóstico de vesículas extracelulares tumorales provenientes de células madre cancerígenas en tumores de mama triple negativo.

IP: Joaquin Seras Franzoso
Collaborators: Laura García Latorre, Diego Baranda Martínez-Abasca, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Belen Garcia Prats
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI22/01301
Duration: 01/01/2023 - 31/12/2025

Vesículas extracelulares para el tratamiento de enfermeades lisosomales (Título provisional)

IP: Ibane Abasolo Olaortua
Collaborators: Laura García Latorre, Guillem Pintos Morell, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Marc Miquel Moltó Abad, Zamira Vanessa Diaz Riascos
Funding agency: Instituto de Salud Carlos III
Funding: 153670
Reference: PI21/00936
Duration: 01/01/2022 - 31/12/2024

Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH

IP: María José Buzón Gómez
Collaborators: Ibane Abasolo Olaortua, Félix Pumarola Segura, Juan Lorente Guerrero, Laura García Latorre, Jordi Temprana Salvador, Joaquin Seras Franzoso, Marc Pellicer Sarasa, David Perea Pérez, Simon Schwartz Navarro, Jordi Navarro Mercadé, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Judit Grau Exposito, Meritxell Genesca Ferrer, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael
Funding agency: Fundació La Marató de TV3
Funding: 199998.75
Reference: 20180510
Duration: 10/05/2019 - 31/12/2022

Terapia combinada mediante nuevos nanoconjugados terapéuticos contra Células Madre Tumorales en tumores de mamas triple negativos

IP: Simon Schwartz Navarro
Collaborators: Laura García Latorre, Joaquin Seras Franzoso, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI17/02242
Duration: 01/01/2018 - 31/12/2020

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Related professionals

Inca Vilar Sastre

Inca Vilar Sastre

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Cristina Prat Vidal

Cristina Prat Vidal

Research assistant
Transfusional Medicine
Read more
Shilena Narci Rodriguez

Shilena Narci Rodriguez

Infectious Diseases
Read more
Marina Llanas Martinez

Marina Llanas Martinez

Predoctoral researcher
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.